However, little information is currently available whether selective inhibition of BCL2 or other anti-apoptotic BCL-2 protein such as BCL(X)L also influences mitochondrial function and energetics in cancer cells [21], and whether these functions can be exploited therapeutically. This evidence concerns the gene BCL2 and cancer.